by HBOT News | Aug 7, 2018 | Stem Cell, Stem Cell News, Stroke
Stroke continues to be an extremely prevalent disease and poses a great challenge in developing safe and effective therapeutic options. Hyperbaric oxygen therapy (HBOT) has demonstrated significant pre-clinical effectiveness for the treatment of acute ischemic stroke, and limited potential in treating chronic neurological deficits. Reported benefits include reductions in oxidative stress, inflammation, neural apoptosis, and improved physiological metrics such as edema and oxygen perfusion, all of which contribute to improved functional recovery.
by HBOT News | Aug 7, 2018 | Infections
Abstract: Hyperbaric oxygen therapy (HBOT) is a treatment procedure that involves breathing 100% O for a certain time and under a certain pressure. HBOT is commonly administrated as a primary or alternative therapy for different diseases such as infections. In this...
by HBOT News | Aug 7, 2018 | Drowning
Abstract: For the most severe drowned patients, hypoxemia represents one of the major symptoms. As the influence of the type of water (fresh or salt water) on respiratory function is still unclear, the primary endpoint of this multicenter study was to compare...
by HBOT News | Aug 3, 2018 | Asthma
Abstract: Long-acting muscarinic antagonist (LAMA) tiotropium improved lung function and reduced risks of exacerbation when added on to inhaled corticosteroids (ICS) with or without long-acting B agonists (LABAs) in patients with uncontrolled asthma. However, studies...
by HBOT News | Aug 2, 2018 | Carbon Monoxide Poisoning
Abstract: Carbon monoxide poisoning is the most commonly seen cause of poisoning in the emergency room (ER). The high affinity between carbon monoxide and hemoglobin and their complex biological characteristics greatly increase the risks of cardiac, nervous, muscular,...
